Pavonine Market Cap

Pavonine has a market cap or net worth of 22.87 billion as of June 30, 2026. Its market cap has decreased by -34.42% in one year.

Market Cap

22.87B

Enterprise Value

79.55B

Revenue

129.02B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,465.00

Market Cap Chart

Since August 4, 2014, Pavonine's market cap has decreased from 49.00B to 22.87B, a decrease of -53.32%. That is a compound annual growth rate of -6.20%.

Market Cap History

Date	Market Cap	% Change
Jun 30, 2026	22.87B	-30.38%
Dec 30, 2025	32.85B	-6.55%
Dec 30, 2024	35.16B	-19.11%
Dec 28, 2023	43.46B	-7.81%
Dec 29, 2022	47.14B	-24.27%
Dec 30, 2021	62.25B	-8.36%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CU Medical Systems	22.84B
Abpro Bio	22.80B
Hanil Chemical Ind.	22.71B
C&R Research	22.68B
CANVAS N	22.54B
HYULIM A-TECH	22.48B
Ranix	22.47B
Daesung Microbiological Labs.	22.42B

Market Cap Rankings